谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A joint profile of cytokines and immune cell populations may identify HNSCC patients who benefit from nivolumab treatment. The Gruppo Oncologico Nord-Ovest (GONO) study Nivactor T-2

Marco Merlano,Matteo Paccagnella,Nerina Denaro,Andrea Abbona,Danilo Galizia,Dario Sangiolo,Loretta Gammaitoni,Erika Fiorino,Silvia Minei,Paolo Bossi,Lisa Licitra,Ornella Garrone

Research Square (Research Square)（2023）

引用 0|浏览38
暂无评分
关键词
nivolumab treatment,cytokines,hnscc patients,immune cell populations,nord-ovest
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要